Searched for: school:SOM
Department/Unit:Plastic Surgery
Fabrication of perfusable microvessels within tissue engineered constructs [Meeting Abstract]
Campbell, Rachel; Hernandez, Karina A; Boyko, Tatiana; Reiffel, Alyssa J; Garcia, Daniel; Joyce, Jeremiah; Derrick, Kadria; Spector, Jason A
ISI:000325577900299
ISSN: 1879-1190
CID: 2654762
Fabrication of cellular tissue constructs from autogenous tissue [Meeting Abstract]
Hernandez, Karina A; Reiffel, Alyssa J; Campbell, Rachel; Derrick, Kadria; Pino, Alejandro; Bleeker, Remco; Harper, Alice; Spector, Jason A
ISI:000325577900189
ISSN: 1879-1190
CID: 2654752
Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure
Tanaka, Rica; Vaynrub, Max; Masuda, Haruchika; Ito, Rie; Kobori, Michiru; Miyasaka, Muneo; Mizuno, Hiroshi; Warren, Stephen M; Asahara, Takayuki
Delayed diabetic wound healing is, in part, the result of inadequate endothelial progenitor cell (EPC) proliferation, mobilization, and trafficking. Recently, we developed a serum-free functional culture system called the quality and quantity culture (QQc) system that enhances the number and vasculogenic potential of EPCs. We hypothesize that QQc restoration of diabetic EPC function will improve wound closure. To test this hypothesis, we measured diabetic c-kit(+)Sca-1(+)lin(-) (KSL) cell activity in vitro as well as the effect of KSL cell-adoptive transfer on the rate of euglycemic wound closure before and after QQc. KSL cells were magnetically sorted from control and streptozotocin-induced type I diabetic C57BL6J bone marrow. Freshly isolated control and diabetic KSL cells were cultured in QQc for 7 days and pre-QQc and post-QQc KSL function testing. The number of KSL cells significantly increased after QQc for both diabetic subjects and controls, and diabetic KSL increased vasculogenic potential above the fresh control KSL level. Similarly, fresh diabetic cells form fewer tubules, but QQc increases diabetic tubule formation to levels greater than that of fresh control cells (P < 0.05). Adoptive transfer of post-QQc diabetic KSL cells significantly enhances wound closure compared with fresh diabetic KSL cells and equaled wound closure of post-QQc control KSL cells. Post-QQc diabetic KSL enhancement of wound closure is mediated, in part, via a vasculogenic mechanism. This study demonstrates that QQc can reverse diabetic EPC dysfunction and achieve control levels of EPC function. Finally, post-QQc diabetic EPC therapy effectively improved euglycemic wound closure and may improve diabetic wound healing.
PMCID:3749357
PMID: 23670975
ISSN: 0012-1797
CID: 540182
Lacunocanalicular fluid flow transduces mechanical tension stress during distraction osteogenesis
Davidson, Edward H; Sultan, Steven M; Butalala, Parag; Knobel, Denis; Warren, Stephen M
The mechanotransduction mechanisms linking distraction device activation to new bone formation remain unknown. We hypothesize that the tension stress of activation during distraction osteogenesis is transmitted through lacunocanalicular fluid flow to initiate the osteogenic signaling cascade. Adult Sprague-Dawley rats (N = 24) were subjected to mandibular osteotomy and application of an external distraction device. After a 3-day latency period, half the animals (n = 12) underwent device activation at 0.25 mm twice daily for 6 days (total activation, 3 mm), and the other half (n = 12) had no activation. On day 10, the animals were injected with fluorescent reactive red lacunocanalicular tracer before killing. Mandibles were harvested, embedded, and sectioned, and reactive red epifluorescence lacunocanalicular flow was measured. Protein was harvested for focal adhesion kinase 1 (FAK1), NESPRIN1, SUN1, LAMIN A/C, and SMAD1 Western blotting as well as for bone morphogenetic protein (BMP)-2 enzyme-linked immunosorbent assay and alkaline phosphatase assay. Lacunocanalicular fluid flow was significantly greater in the distracted samples (60.5 +/- 14 vs 10.3 +/- 4 molecules of equivalent soluble fluorochrome per megapixel, P = 0.01). Flow distribution demonstrated the highest lacunocanalicular flow near the center of the distraction gap. Increased lacunocanalicular flow resulted in increased FAK1 (P = 0.009), NESPRIN1 (P = 0.01), SUN1 (P = 0.01), and LAMIN A/C (P = 0.008) expression. Focal adhesion kinase 1 activation in the presence of BMP-2 protein expression (P = 0.001) resulted in increased intranuclear SMAD1 phosphorylation (P = 0.04) and alkaline phosphatase activity (P < 0.0001). These findings suggest that activation of the distraction osteogenesis device affects cellular response through changes in lacunocanalicular fluid flow.
PMID: 24036726
ISSN: 1049-2275
CID: 541842
The NYU experience with free fibula reconstruction of the mandible utilizing virtual surgical planning [Meeting Abstract]
Franco, P B; Hirsch, D L; Levine, J; Avraham, T
Statement of the Problem: The use of free osseous flaps has become the gold standard for reconstruction of complex mandibular defects. Popularized by Hidalgo1 in 1989, the free fibula transfer has become the operation of choice for these indications. While this operation has become routine; contouring of the flap using wedge osteotomies, as well as its inset remain operator dependent and imprecise. At our institution we have attempted to make this process more uniform and reproducible through the use of virtual planning and pre-fabricated cutting jigs. We have previously reported our experience on computer-aided design and manufacturing;2 however the purpose of this study was to review our series of free fibula mandibular reconstructions using these adjunctive technologies. Methods: Prior to surgery all patients underwent CT scanning of the face and bilateral lower extremities. These images were then transmitted to an outside vendor. In consultation with both the ablative and reconstructive teams, a surgical plan was devised and performed virtually, cutting jigs for both creation of the mandibular defect and for fibular osteotomies were fabricated, and a stereolithicmodel that allows for precise pre-surgical bending of a reconstruction platewas created. The rest of the surgical procedure was performed in standard fashion. Following IRB approval, all cases between 2009 and 2012 were identified and retrospectively reviewed. In addition to patient demographics, the charts were reviewed for surgical indications, microvascular anastomoses, use of a skin paddle, use of a "double barrel", timing of dental implant placement (immediate versus delayed), and timing of dental prosthetic rehabilitation (immediate versus delayed). Methods of Data Analysis: This was a retrospective chart review from 2009 to the present. Fifty-four reconstructionswere identified as having undergone presurgical virtual planning and subsequent surgery for mandibular reconstruction with microvascular free fibula transfer. Patient!
EMBASE:71166041
ISSN: 0278-2391
CID: 549962
RE: An algorithm for the safety of costal diaphragm electromyography derived from ultrasound [Letter]
Saadeh, Peter B; Saadeh, Pierre B
PMID: 23512846
ISSN: 0148-639x
CID: 379152
Reanimation of facial palsy following tumor extirpation in pediatric patients: Our experience with 16 patients
Terzis, Julia K; Konofaos, Petros
The aim of this study was to present our experience with reanimation of facial palsy (FP) following tumor extirpation in pediatric patients and to analyze the functional outcomes based on different types of procedures performed considering demographic and electrophysiological data of the patients. Sixteen patients with FP post-tumor extirpation who underwent facial reanimation were reviewed. Three independent assessors evaluated the preoperative and postoperative videos using the Terzis' grading scale for eye closure, smile, depressor and overall esthetic and functional outcomes. Preoperative and postoperative electromyographic interpretations and the effect of demographic variables were also evaluated. There was significant improvement in all the patients regarding overall esthetic and functional outcomes (p < 0.0001). Good and excellent overall esthetic and functional outcomes were observed in 62.50% of the patients (n = 10). The difference between preoperative and postoperative EMG results was of statistical significance (p < 0.0001 for each target re-innervated). Better results were observed in younger patients (=10 years) (p = 0.014) and in early cases (denervation time =2 years) (p = 0.033). Functional results were significantly better if surgery was performed within 2 years and the patient was younger than 10 years. Augmentation of the paretic facial musculature in pediatric patients with post-tumor FP was feasible with the use of dynamic and/or static procedures. Advanced microsurgical techniques, such as the use of free muscle transfers, should be kept in mind in late cases (denervation time over 2 years).
PMID: 23664575
ISSN: 1748-6815
CID: 463522
Methylation as a mechanism of cisplatin resistance in head and neck cancer [Meeting Abstract]
Viet, C T; Dang, D; Ye, Y; Schmidt, B L
Cisplatin is the primary chemotherapy for head and neck squamous cell carcinoma (HNSCC). No equally effective chemotherapeutics are available when cisplatin resistance occurs. We hypothesize that DNA methylation of key genes mediates cisplatin resistance; moreover, pretreatment with decitabine, a demethylating agent, restores cisplatin sensitivity by mediating expression of genes that are instrumental to cisplatin resistance. Objectives: 1) Determine whether decitabine treatment of a cisplatin-resistant HNSCC cell line restores the anti-proliferative and apoptotic effects of cisplatin; 2) Evaluate the anti-proliferative effect of decitabine and cisplatin (i.e. combination treatment) on a preclinical HNSCC model; 3) Determine whether combination treatment reduces cancer pain; and 4) Create a "gene expression profile of cisplatin resistance" by analyzing cisplatinsensitive and cisplatin-resistant HNSCC in patients. Methods: SCC-25, a cisplatin-sensitive HNSCC cell line, and SCC-25/CP, a cisplatin-resistant cell line, were pre-treated with 5mM decitabine and then treated with cisplatin (3-300 mM) for 48 hours. Proliferation was quantified with an MTS assay. Apoptosis was quantified with a caspase 3/7 assay. A preclinical model was created by inoculating SCC-25/CP cells into the hind-paw of BALB/ c mice. Twenty-four mice were placed into one of four treatment groups: control sham, decitabine-only, cisplatin- only, or combination treatment. Decitabine (6 mg/kg) was administered on post-inoculation days (PID) seven and nine, and cisplatin (6 mg/kg) was administered on PID 12, 15, 18, and 21. Tumor growth was quantified. Mechanical allodynia (i.e. pain) was quantified with a paw withdrawal assay. Formalin-fixed, paraffin- embedded biopsies were obtained from HNSCC patients who underwent chemotherapy with cisplatin. Tumors were classified as either cisplatin-sensitive (RECIST 3 or 4) or cisplatin-resistant (RECIST 1 or 2). Gene expression was quantified in these two sets of samples. Results: In the in !
EMBASE:71166045
ISSN: 0278-2391
CID: 549502
Diverse indications for zygomaticus implants-a case series [Meeting Abstract]
Franco, P B; Bourell, L; Brecht, L; Hirsch, D L
Statement of the Problem: Reconstruction of the atrophic edentulousmaxilla canbe a challenge, particularly in individuals where extensive bone grafting is required prior to dental implant placement or in patients where bone grafts have been tried and failed. Likewise, dental rehabilitation after tumor ablation and reconstruction can be problematic if there is inadequate maxillary bone to support traditional dental implants. Zygomaticus implants, which make use of the dense type I-II bone of the zygoma, are one solution that allows for dental implant reconstruction of the atrophic or reconstructed maxilla. Materials and Methods, Data Analysis: We performed a retrospective chart review of all patients who received dental implants in the operating room at two of our affiliated hospitals from June 2007 to March 2013. We identified those patients who received either unilateral or bilateral zygomaticus implants.We then collected available data including gender, diagnosis, adjunctive surgical procedures, and indication for zygomaticus implants. Patients receiving zygomaticus implants following maxillectomy procedures were compared to a cohort of patients who did not receive implants following maxillectomy to determine which variables may have influenced surgeon choice of zygomaticus implants. In addition, we report on two recent cases of zygomaticus implants placed followingenucleation of maxillary bone cysts. Follow-up was available for all patients and ranged from one month to five years. All implants were placed by and with the supervision of a single attending surgeon, DLH. Results: From 2007 to 2013, a total of 25 zygomaticus implants were placed in 12 patients at two affiliated hospitals. Indications for zygomatic implants were varied. Patients received zygomatic implantation for cleft reconstruction, maxillectomy defect with and without free tissue transfer, and atrophic maxilla not amenable to traditional implant surgery. Two patients received bilateral zygomaticus implants for a diagnosis of !
EMBASE:71166128
ISSN: 0278-2391
CID: 549932
Litigation and Legislation. You made my heart stop
Jerrold, Laurance
PMID: 23992821
ISSN: 1097-6752
CID: 1992102